Table 4.

Univariable analysis for factors associated with NAFLD.

Variables	β	SE	Wald χ2	P value	OR	95% CI
Gender (male/female)	1.076	0.039	779.067	<0.001	2.932	2.719–3.162
Age (year)	0.026	0.002	305.080	<0.001	1.027	1.024–1.030
BMI (kg/m2)	0.453	0.009	2680.124	<0.001	1.573	1.546–1.600
Waist circumference (cm)	0.164	0.003	2635.793	<0.001	1.178	1.171–1.186
Systolic blood pressure (mmHg)	0.039	0.001	1158.020	<0.001	1.040	1.037–1.042
Diastolic blood pressure (mmHg)	0.064	0.002	1259.274	<0.001	1.066	1.062–1.070
Alanine aminotransferase (U/L)	0.045	0.001	999.223	<0.001	1.046	1.043–1.048
Aspartate aminotransferase (U/L)	0.037	0.002	262.613	<0.001	1.038	1.033–1.042
γ-Glutamyl transferase (U/L)	0.017	0.001	674.271	<0.001	1.017	1.016–1.019
Triglyceride (mmol/L)	1.045	0.026	1587.221	<0.001	2.844	2.701–2.994
Total cholesterol (mmol/L)	0.437	0.020	461.541	<0.001	1.548	1.488–1.611
HDL-C (mmol/L)	-2.418	0.069	1241.847	<0.001	0.089	0.078–0.102
LDL-C (mmol/L)	0.378	0.027	201.467	<0.001	1.459	1.385–1.538
Fasting plasma glucose (mmol/L)	0.613	0.025	590.743	<0.001	1.845	1.756–1.939
HbA1c (%)	0.784	0.037	444.916	<0.001	2.191	2.037–2.357
Serum uric acid (μmol/L)	0.009	0.000	1563.673	<0.001	1.009	1.009–1.010
MHR	0.177	0.009	424.782	<0.001	1.193	1.173–1.213

BMI: body mass index; β: partial regression coefficient; HbA1c: glycated hemoglobin A1c; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; MHR: monocyte to HDL-C ratio; NAFLD: nonalcoholic fatty liver disease; SE: standard error of partial regression coefficient.